{"id":52551,"url":"https://lda.senate.gov/api/v1/clients/52551/?format=json","client_id":52551,"name":"CAPTURA BIOPHARMA","general_description":"Captura is developing an orally administered MCM for radionuclide contamination.","client_government_entity":null,"client_self_select":false,"state":"AR","state_display":"Arkansas","country":"US","country_display":"United States of America","ppb_state":"AL","ppb_state_display":"Alabama","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-07-15","registrant":{"id":401106159,"url":"https://lda.senate.gov/api/v1/registrants/401106159/?format=json","house_registrant_id":null,"name":"HORIZONS GLOBAL SOLUTIONS LLC","description":"Consulting and Government Affairs","address_1":"100 Church Street","address_2":"Suite 200","address_3":null,"address_4":null,"city":"Huntsville","state":"AL","state_display":"Alabama","zip":"35801","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID F. LASSETER","contact_telephone":"+1 706-718-9697","dt_updated":"2026-01-26T14:59:27.475985-05:00"}}